Perform Another (Advanced) Search

1.  Study Posting (1570) Trial #156483, Atrial Fibrillation, Morristown, NJ
...long-term Vitamin-K antagonist (VKA) therapy based on the presence of previous ischemic stroke, transient ischemic attack or systemic embolism and/or at least two of the following risk factors: hypertension ...
View Page

2.  Study Posting (5479) Trial #162088, Atrial Fibrillation, Wauwatosa, WI
...long-term Vitamin-K antagonist (VKA) therapy based on the presence of previous ischemic stroke, transient ischemic attack or systemic embolism and/or at least two of the following risk factors: hypertension ...
View Page

3.  Study Posting (5479) Trial #162087, Atrial Fibrillation, Madison, WI
...long-term Vitamin-K antagonist (VKA) therapy based on the presence of previous ischemic stroke, transient ischemic attack or systemic embolism and/or at least two of the following risk factors: hypertension ...
View Page

4.  Study Posting (5479) Trial #162086, Atrial Fibrillation, Beloit, WI
...long-term Vitamin-K antagonist (VKA) therapy based on the presence of previous ischemic stroke, transient ischemic attack or systemic embolism and/or at least two of the following risk factors: hypertension ...
View Page

5.  Study Posting (5479) Trial #162085, Atrial Fibrillation, Tacoma, WA
...long-term Vitamin-K antagonist (VKA) therapy based on the presence of previous ischemic stroke, transient ischemic attack or systemic embolism and/or at least two of the following risk factors: hypertension ...
View Page

6.  Study Posting (5479) Trial #162084, Atrial Fibrillation, Seattle, WA
...long-term Vitamin-K antagonist (VKA) therapy based on the presence of previous ischemic stroke, transient ischemic attack or systemic embolism and/or at least two of the following risk factors: hypertension ...
View Page

7.  Study Posting (5479) Trial #162083, Atrial Fibrillation, Everett, WA
...long-term Vitamin-K antagonist (VKA) therapy based on the presence of previous ischemic stroke, transient ischemic attack or systemic embolism and/or at least two of the following risk factors: hypertension ...
View Page

8.  Study Posting (5479) Trial #162082, Atrial Fibrillation, Salem, VA
...long-term Vitamin-K antagonist (VKA) therapy based on the presence of previous ischemic stroke, transient ischemic attack or systemic embolism and/or at least two of the following risk factors: hypertension ...
View Page

9.  Study Posting (5479) Trial #162081, Atrial Fibrillation, Burke, VA
...long-term Vitamin-K antagonist (VKA) therapy based on the presence of previous ischemic stroke, transient ischemic attack or systemic embolism and/or at least two of the following risk factors: hypertension ...
View Page

10.  Study Posting (5479) Trial #162080, Atrial Fibrillation, Salt Lake City, UT
...long-term Vitamin-K antagonist (VKA) therapy based on the presence of previous ischemic stroke, transient ischemic attack or systemic embolism and/or at least two of the following risk factors: hypertension ...
View Page

11.  Study Posting (5479) Trial #162079, Atrial Fibrillation, Salt Lake City, UT
...long-term Vitamin-K antagonist (VKA) therapy based on the presence of previous ischemic stroke, transient ischemic attack or systemic embolism and/or at least two of the following risk factors: hypertension ...
View Page

12.  Study Posting (5479) Trial #162078, Atrial Fibrillation, Clinton, UT
...long-term Vitamin-K antagonist (VKA) therapy based on the presence of previous ischemic stroke, transient ischemic attack or systemic embolism and/or at least two of the following risk factors: hypertension ...
View Page

13.  Study Posting (5479) Trial #162077, Atrial Fibrillation, Wichita Falls, TX
...long-term Vitamin-K antagonist (VKA) therapy based on the presence of previous ischemic stroke, transient ischemic attack or systemic embolism and/or at least two of the following risk factors: hypertension ...
View Page

14.  Study Posting (5479) Trial #162076, Atrial Fibrillation, Victoria, TX
...long-term Vitamin-K antagonist (VKA) therapy based on the presence of previous ischemic stroke, transient ischemic attack or systemic embolism and/or at least two of the following risk factors: hypertension ...
View Page

15.  Study Posting (5479) Trial #162075, Atrial Fibrillation, Temple, TX
...long-term Vitamin-K antagonist (VKA) therapy based on the presence of previous ischemic stroke, transient ischemic attack or systemic embolism and/or at least two of the following risk factors: hypertension ...
View Page

16.  Study Posting (5479) Trial #162074, Atrial Fibrillation, San Antonio, TX
...long-term Vitamin-K antagonist (VKA) therapy based on the presence of previous ischemic stroke, transient ischemic attack or systemic embolism and/or at least two of the following risk factors: hypertension ...
View Page

17.  Study Posting (5479) Trial #162073, Atrial Fibrillation, Odessa, TX
...long-term Vitamin-K antagonist (VKA) therapy based on the presence of previous ischemic stroke, transient ischemic attack or systemic embolism and/or at least two of the following risk factors: hypertension ...
View Page

18.  Study Posting (5479) Trial #162072, Atrial Fibrillation, Odessa, TX
...long-term Vitamin-K antagonist (VKA) therapy based on the presence of previous ischemic stroke, transient ischemic attack or systemic embolism and/or at least two of the following risk factors: hypertension ...
View Page

19.  Study Posting (5479) Trial #162071, Atrial Fibrillation, Irving, TX
...long-term Vitamin-K antagonist (VKA) therapy based on the presence of previous ischemic stroke, transient ischemic attack or systemic embolism and/or at least two of the following risk factors: hypertension ...
View Page

20.  Study Posting (5479) Trial #162070, Atrial Fibrillation, Houston, TX
...long-term Vitamin-K antagonist (VKA) therapy based on the presence of previous ischemic stroke, transient ischemic attack or systemic embolism and/or at least two of the following risk factors: hypertension ...
View Page